145 related articles for article (PubMed ID: 172008)
21. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Schinazi RF; Peters J; Sokol MK; Nahmias AJ
Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of herpes simplex virus encephalitis in mice by direct intracerebral injection.
Cameron KR; Adams DH
J Infect Dis; 1979 Dec; 140(6):921-6. PubMed ID: 94338
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of inhibition of deoxyribonucleic acid synthesis by 1-beta-D-arabinofuranosyladenosine triphosphate and its potentiation by 6-mercaptopurine ribonucleoside 5'-monophosphate.
Lee MY; Byrnes JJ; Downey KM; So AG
Biochemistry; 1980 Jan; 19(1):215-9. PubMed ID: 6153266
[TBL] [Abstract][Full Text] [Related]
25. Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine.
Sidwell RW; Allen LB; Huffman JH; Khwaja TA; Tolman RL; Robins RK
Chemotherapy; 1973; 19(6):325-40. PubMed ID: 4367867
[No Abstract] [Full Text] [Related]
26. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
[TBL] [Abstract][Full Text] [Related]
28. Therapy of experimental herpes simplex encephalitis with aciclovir in mice.
Park NH; Pavan-Langston D; McLean SL; Albert DM
Antimicrob Agents Chemother; 1979 Jun; 15(6):775-9. PubMed ID: 475362
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
Schwartz PM; Novack J; Shipman C; Drach JC
Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827
[TBL] [Abstract][Full Text] [Related]
30. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
De Clercq E; Luczak M
J Infect Dis; 1976 Jun; 133 Suppl():A226-36. PubMed ID: 180205
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
Marks MI
J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
[TBL] [Abstract][Full Text] [Related]
32. Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate.
Preiksaitis JK; Lank B; Ng PK; Brox L; LePage GA; Tyrrell DL
J Infect Dis; 1981 Oct; 144(4):358-64. PubMed ID: 6169773
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy of herpes encephalitis].
Mertens T
Immun Infekt; 1986 Jul; 14(4):143-7. PubMed ID: 2427437
[TBL] [Abstract][Full Text] [Related]
35. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals.
Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
Hess G; Arnold W; Meyer zum Büschenfelde KH
Antimicrob Agents Chemother; 1981 Jan; 19(1):44-50. PubMed ID: 6166246
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
Klein RJ; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
[TBL] [Abstract][Full Text] [Related]
38. Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
O'Brien WJ
Curr Eye Res; 1986 Aug; 5(8):595-9. PubMed ID: 3489583
[TBL] [Abstract][Full Text] [Related]
39. [Preliminary clinical experiences with adenine arabinoside monophosphate (ARA-AMP) in encephalitis due to viruses of the herpes group and varicella/zoster infections (author's transl)].
Sauer O; Werner GT; Schneider H; Lenard HG; von Haselberg L; Nettesheim HJ
Klin Padiatr; 1979 Nov; 191(6):566-71. PubMed ID: 92592
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and anti-deoxyribonucleic acid virus activity of certain 9-beta-D-arabinofuranosyl-2-substituted adenine derivatives.
Miyai K; Allen LB; Huffman JH; Sidwell RW; Tolman RL
J Med Chem; 1974 Feb; 17(2):242-4. PubMed ID: 4358433
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
